84
Views
0
CrossRef citations to date
0
Altmetric
Original Research

Factor Analysis of Metabolic Syndrome and Its Relationship with the Risk of Cardiovascular Disease in Ethnic Populations in Rural Xinjiang, China

, , , , , , , , , , ORCID Icon, , & ORCID Icon show all
Pages 4317-4325 | Published online: 10 Aug 2021

References

  • Hu S, Gao R, Liu L, et al. Summary of the 2018 report on cardiovascular diseases in China. Chin Circ J. 2019;34(03):209–220.
  • Eckel R, Grundy S, Zimmet P. The metabolic syndrome. Lancet. 2005;366(9501):1923. doi:10.1016/S0140-6736(05)67781-1
  • Wilson PW, D’Agostino RB, Levy D, Belanger AM, Silbershatz H, Kannel WB. Prediction of coronary heart disease using risk factor categories. Circulation. 1998;97(18):1837–1847. doi:10.1161/01.CIR.97.18.1837
  • Zhu Z, Liu Y, Zhang C, et al. Identification of cardiovascular risk components in urban Chinese with metabolic syndrome and application to coronary heart disease prediction: a longitudinal study. PLoS One. 2013;8(12):e84204. doi:10.1371/journal.pone.0084204
  • Ma X, Zhang M, Guo S, et al. Prevalence of hypertension in Uygur, Kazakhs and Han people in rural areas of Xinjiang. Chin J Hypertens. 2013;21(12):1164–1168.
  • Qin X, Qiu L, Tang G, Tsoi MF, Cheung BMY. Prevalence of metabolic syndrome among ethnic groups in China. BMC Public Health. 2020;20(1). doi:10.1186/s12889-020-8393-6
  • He J, Guo H, Ding Y, et al. Epidemiological study on overweight and obesity among rural adult residents in Hazakh, Uygur and Han populations in Xinjiang. Chin J Epidemiol. 2013;34(12):1164–1168.
  • Alberti KG, Eckel RH, Grundy SM, et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation. 2009;120(16):1640–1645.
  • Investigators WMPP. The World Health Organization MONICA Project (monitoring trends and determinants in cardiovascular disease): a major international collaboration. WHO MONICA Project Principal Investigators. J Clin Epidemiol. 1988;41(2):105–114. doi:10.1016/0895-4356(88)90084-4
  • Liu W, Hu B, Dehghan M, et al. Fruit, vegetable, and legume intake and the risk of all-cause, cardiovascular, and cancer mortality: a prospective study. Clin Nutr. 2021;40(6):4316–4323. doi:10.1016/j.clnu.2021.01.016
  • Lindbohm J, Sipilä P, Mars N, et al. Association between change in cardiovascular risk scores and future cardiovascular disease: analyses of data from the Whitehall II longitudinal, prospective cohort study. Lancet Digit Health. 2021;3(7):e434–e444.
  • Li R, Li W, Lun Z, et al. Prevalence of metabolic syndrome in Mainland China: a meta-analysis of published studies. BMC Public Health. 2016;16:296. doi:10.1186/s12889-016-2870-y
  • do Vale Moreira NC, Hussain A, Bhowmik B, Mdala I, Meyer HE. Prevalence of Metabolic Syndrome by different definitions, and its association with type 2 diabetes, pre-diabetes, and cardiovascular disease risk in Brazil. Diabetes Metab Syndr Clin Res Rev. 2020;14(5):1217–1224.
  • Yang X, Li J, Hu D, et al. Predicting the 10-year risks of atherosclerotic cardiovascular disease in Chinese Population: the China-PAR Project (Prediction for ASCVD Risk in China). Circulation. 2016;134(19):1430–1440. doi:10.1161/CIRCULATIONAHA.116.022367
  • Sun Z, Zhang Q, Xu S, et al. A study on four different risk assessment models to assess the 10-year cardiovascular disease risk of people over 40 years old in Guiyang. Guizhou Med J. 2018;42(8):1007–1010.
  • Hajian-Tilaki K. Factor analysis of metabolic syndrome components in an iranian non-diabetic adult population: a population-based study from the north of Iran. Int J Endocrinol Metab. 2018;16(2):e14159. doi:10.5812/ijem.14159
  • Lai XF, Fang Q, Yang LL, et al. Direct, indirect and total bilirubin and risk of incident coronary heart disease in the Dongfeng-Tongji cohort. Ann Med. 2018;50(1):16–25. doi:10.1080/07853890.2017.1377846
  • Doganer YC, Rohrer JE, Aydogan U, Agerter DC, Cayci T, Barcin C. Atherosclerosis and liver function tests in coronary angiography patients. West Indian Med J. 2015;64(4):333–337.
  • Lee S, Park W, Suh Y, et al. Association of serum uric acid with cardiovascular disease risk scores in Koreans. Int J Environ Res Public Health. 2019;16(23):4632.
  • Zhang X, Li Y, Zhang X. Diagnostic value of combined detection of myocardial enzymes, Hcy and PCT in coronary heart disease. Chin Foreign Med Res. 2021;19(10):87–89.
  • Zhou J, Yao H, Wang H, et al. Epidemic features of dyslipidemia among Uygur, Kazakh and Han ethnic groups in Urumqi. Natl Med J China. 2016;38(96):3090–3093.
  • Chen X, Barywani SB, Hansson PO, Rosengren A, Fu MJM. High-normal blood pressure conferred higher risk of cardiovascular disease in a random population sample of 50-year-old men: a 21-year follow-up. Medicine. 2020;99(17):e19895.
  • Tian G. Prospective Cohort Study of the Relationship between Blood Pressure and Fasting Blood Glucose with All-Cause and Cardiovascular Disease Mortality [dissertation]. Zhengzhou University; 2020.
  • Guo S, Mao L, Liao P, et al. Using metabolic related factors constructing a predictive model for the risk of cardiovascular diseases in Xinjiang Kazakh population. Chin J Endocrinol Metab. 2020;01:51–57.
  • Jiang Y, Ma R, Guo H, et al. External validation of three atherosclerotic cardiovascular disease risk equations in rural areas of Xinjiang, China. Bmc Public Health. 2020;20(1). doi:10.1186/s12889-020-09579-4